| CALYX | |
| Type: | Private |
| Key People: | CEO: David Herron |
| Industry: | Clinical research organizations Pharmaceutical |
| Parent: | CapVest Partners/GLO Healthcare |
| Services: | Medical imaging, clinical trial management systems |
| Num Employees: | 1000-2000[1] |
| Foundation: | 2021 |
| Location: | Nottingham, United Kingdom[2] |
| Num Locations: | 12+ facilities in 10+ countries |
| Revenue: | $82 million (2022)[3] [4] |
Calyx, formerly Parexel Informatics,[5] is a corporate spin-off from Parexel International.[3] [6] Calyx is a British–American provider of biopharmaceutical services.[7] The company was formed in January 2021 following the strategic separation of the Parexel Informatics business from Parexel International, and provides medical imaging, e-clinical and regulatory services.[8]